Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.490 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2006 | 2016 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.350 | None | 1.000 | 0 | 0 | 2004 | 2010 | ||||||||
|
axin 2 | 0.507 | 0.692 | 0.57 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 2004 | 2006 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase B | 0.502 | 0.808 | 7.0E-10 |
|
group | 0.330 | None | 1.000 | 0 | 0 | 2002 | 2009 | ||||||||
|
folliculin | 0.537 | 0.885 | 0.79 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2003 | 2003 | ||||||||
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2002 | 2002 | ||||||||
|
polypeptide N-acetylgalactosaminyltransferase 12 | 0.780 | 0.269 | 9.4E-07 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2004 | 2004 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
group | 0.420 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
bone morphogenetic protein 4 | 0.422 | 0.808 | 0.96 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
Kruppel like factor 5 | 0.534 | 0.769 | 0.82 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
BOC cell adhesion associated, oncogene regulated | 0.666 | 0.423 | 1.7E-07 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
group | 0.410 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
nucleoredoxin | 0.584 | 0.577 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2014 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
SMAD family member 9 | 0.666 | 0.308 | 6.4E-05 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
rhophilin Rho GTPase binding protein 2 | 0.711 | 0.192 | 1.1E-07 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
lysophosphatidic acid receptor 1 | 0.534 | 0.808 | 0.19 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2019 | 2019 |